BRIEF-Conduent Announces Agreement To Sell Its Casualty Claims Solutions Business To Medrisk-August 2024-www.financetom.com

BRIEF-Conduent Announces Agreement To Sell Its Casualty Claims Solutions Business To Medrisk

News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities

BRIEF-Conduent Announces Agreement To Sell Its Casualty Claims Solutions Business To Medrisk

May 3, 2024 6:41 AM

May 3 (Reuters) - Conduent Inc ( CNDT ):

* CONDUENT ANNOUNCES AGREEMENT TO SELL ITS CASUALTY CLAIMS

SOLUTIONS BUSINESS TO MEDRISK

* CONDUENT INC ( CNDT ): SALE, FOR $240 MILLION IN CASH

* CONDUENT INC ( CNDT ) - AS PART OF THIS TRANSACTION, CURRENT

CONDUENT

EMPLOYEES IN CASUALTY CLAIMS SOLUTIONS BUSINESS WILL JOIN

MEDRISK

* CONDUENT INC ( CNDT ) - CONDUENT WILL CONTINUE TO PROVIDE MAILROOM

SERVICES FOR CURRENT CASUALTY CLAIMS CLIENTS INCLUDING MEDRISK

Source text for Eikon:

Further company coverage:

Previous page： Apparel retailer Boot Barn beats Q2 sales estimates Next page： Starbucks Fiscal Q4 Non-GAAP Earnings Fall, Revenue Rises

Comments

Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.

Show More Comments

Related Articles >

Apparel retailer Boot Barn beats Q2 sales estimates

Oct 29, 2025

Overview * Boot Barn ( BOOT ) fiscal Q2 net sales grow 18.7%, beating analyst expectations * Net income for fiscal Q2 rises to $42.2 mln, EPS at $1.37 * Company announces increased store count potential of 1,200 stores Outlook * Boot Barn ( BOOT ) expects FY 2026 sales of $2.197 bln to $2.235 bln * Company plans to...

Starbucks Fiscal Q4 Non-GAAP Earnings Fall, Revenue Rises

Oct 29, 2025

04:13 PM EDT, 10/29/2025 (MT Newswires) -- Starbucks ( SBUX ) reported fiscal Q4 non-GAAP earnings late Wednesday of $0.52 per diluted share, down from $0.80 a year earlier Analysts surveyed by FactSet expected $0.56. Revenue for the three months ended Sept. 28 was $9.57 billion, up from $9.07 billion a year earlier. Analysts polled by FactSet expected $9.33 billion....

BridgeBio Pharma Q3 Loss Widens, Revenue Jumps; Shares Drop After Hours

Oct 29, 2025

05:00 PM EDT, 10/29/2025 (MT Newswires) -- BridgeBio Pharma ( BBIO ) reported a Q3 loss late Wednesday of $0.95 per diluted share, versus a $0.86 loss a year earlier. Analysts polled by FactSet expected a loss of $0.89. Net sales for the quarter ended Sept. 30 were $120.7 million, up from $2.73 million a year earlier. Analysts surveyed by...

Tenaris Q3 Earnings, Revenue Rise

Oct 29, 2025

05:00 PM EDT, 10/29/2025 (MT Newswires) -- Tenaris ( TS ) reported Q3 earnings late Wednesday of $0.85 per American Depositary share, up from $0.81 a year earlier. Analysts polled by FactSet expected $0.77. Revenue for the three months ended Sept. 30 was $2.98 billion, up from $2.92 billion a year earlier. Analysts surveyed by FactSet expected $2.84 billion. The...